Nearly half (49%) of cancer patients and survivors report being burdened by medical debt alongside some (13%) who report expecting to incur medical debt as part of their treatment plan, according to a new Survivor Views survey by the American Cancer Society Cancer Action Network (ACS CAN).
Today, the Food and Drug Administration (FDA) finalized a new rule regulating laboratory developed tests (LDTs) that will harmonize oversight for diagnostic tests regardless of whether tests are performed in individual laboratories or sold as prepackaged kits.
Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network and peer institutions released new findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer, or 21.9%, participate in some form of clinical research.
Rhode Island lawmakers have taken the first step towards improving prescription drug affordability for cancer patients and others with chronic diseases.
PHOENIX, ARIZ.– March 5, 2024 – Governor Katie Hobbs announced a new plan to eliminate medical debt for up to 1 million people in Arizona, Monday morning. As part of “Affordable Arizona: Tackling Medical Debt for Working Families” program, the state will partner with RIP Medical Debt to buy back medical debt over the next two years.
WASHINGTON, D.C.—February 23, 2024—As organizations dedicated to ending cancer as we know it for everyone, the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), are deeply concerned about a recent decision by the Supreme Court
Protecting free preventive cancer screenings and reducing the burden of medical debt are the top issues of concern for cancer patients and survivors today, according to a new survey by the American Cancer Society Cancer Action Network (ACS CAN) that asked participants to select their leading policy priorities for the year.
WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) was joined by 20 other organizations in proposing the Health and Human Services Office of Inspector General adopt a new regulatory safe harbor from the Anti-kickback Statute that would allow cli
JEFFERSON CITY, Mo.
New findings led by researchers at the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) show that regional trial eligibility screening holds the promise of substantially increasing the number of patients who are found eligible to enroll in cancer clinical trials.